Sound Ventures Founder Ashton Kutcher. Sound Ventures participated in the funding round. Photo credit: Steve Jennings/Getty Images for TechCrunch, under Creative Commons license

Truepill, a white-label healthcare services company, has announced that it’s raised $75 million in Series C funding from investors including Oak HC/FT, which led the round, with participation from the likes of Optum Ventures, TI Platform Management, Sound Ventures, and YCombinator. With the new funding, Truepill has now raised a total of $114 million in funding since its inception. Truepill says it’ll use the new capital to launch an at-home lab testing network, marking a new service that’ll further expand the company’s ecosystem of direct-to-patient healthcare services. 

Truepill powers direct-to-patient health services for digital healthcare companies. Popular names in the industry such as Hims, GoodRx, and Nurx are Truepill customers. The company develops software that power health-centric services including patient onboarding, medication deliveries, and telehealth consultations. It also operates in its own pharmacies across the US. Truepill’s services are currently available in the U.S. and U.K. 

Truepill was founded in 2016.

Share this...

Facebook

Pinterest

Twitter

Linkedin

Whatsapp

Email

Print